FTLA Insights is designed to move beyond theory and into practice. Each edition shares quarterly summaries of our FTLA events, webinars, and real-world insights from emerging biopharma companies.
First-time launches remain defining moments for emerging biopharma companies. Success hinges not only on scientific and regulatory achievements but on cross-functional orchestration – strategy, operations, supply chain, market access, and enabling functions all working in lockstep.
We hope FTLA Insights sparks fresh thinking and provides practical guidance as you prepare for your own launch – whether in the USA, Europe, or beyond.
Download: FTLA Insights – Q1 2026 Summary Edition
A unique, collaborative forum for leaders in emerging biotech companies—from pre-IND to first launch, partnership, or acquisition